PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1423555
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1423555
Influenza Diagnostic Tests Market Forecasts to 2030 - Global Analysis By Test Type, End User, and By Geography
According to Stratistics MRC, the Global Influenza Diagnostic Tests Market is accounted for $1.1 billion in 2023 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 5.6% during the forecast period. Influenza diagnostic tests are medical procedures designed to identify the presence of influenza viruses in individuals experiencing respiratory symptoms. Emerging technologies, such as loop-mediated isothermal amplification (LAMP) and nucleic acid sequence-based amplification (NASBA), offer faster and simpler alternatives. Rapid and accurate diagnosis is crucial for prompt treatment and effective public health measures that amplify and detect viruses, providing accurate results.
According to estimates by the Centers for Disease Control and Prevention, there were 9 million flu cases, 4 million influenza-related medical appointments, 100,000 flu-related hospitalizations, and 5,000 flu-related fatalities during the 2021-2022 seasons in the U.S. Similar to recent seasons preceding the COVID-19 outbreak, 83% of fatalities were caused by older people.
Market Dynamics:
Driver:
Increased awareness and education
Health literacy programs educate individuals on recognizing influenza symptoms, understanding the potential severity of the disease, and appreciating the role of diagnostic tests in effective treatment and prevention. Public health campaigns, educational initiatives, and communication efforts contribute to raising awareness among healthcare professionals and the general public. Furthermore, healthcare providers are better equipped to recognize and respond to influenza cases, which are boosting this market expansion.
Restraint:
High cost
The high costs associated with influenza diagnostic tests can deter healthcare providers and patients from utilizing them, particularly in resource-limited settings or regions with constrained healthcare budgets. This can result in underdiagnosis, delayed treatment, and compromised disease management. In addition, there may be additional expenses related to test administration, such as professional fees and specimen collection supplies, hampering market growth.
Opportunity:
Advancements in diagnostic technologies
Molecular diagnostic technologies, notably reverse transcription-polymerase chain reaction (RT-PCR), have seen remarkable progress, offering heightened sensitivity and specificity in detecting influenza viruses. These advancements enable rapid and accurate identification of viral strains, aiding healthcare professionals in timely decision-making and patient management. Moreover, immunoassays and nucleic acid amplification techniques continue to evolve, contributing to a diverse array of diagnostic options, thereby driving this market size.
Threat:
Lack of awareness
Healthcare providers may not be familiar with the advantages, limitations, and proper interpretation of the results associated with each test. This can lead to underutilization or inappropriate utilization of diagnostic tests, potentially resulting in delayed diagnosis and suboptimal patient management. Moreover, many individuals may not be aware of its importance, which contributes to a lower demand for testing services, leading to missed opportunities for early detection and effective disease control and impeding this market.
Covid-19 Impact
The COVID-19 pandemic has had a negative impact on the influenza diagnostic test market in several ways. Healthcare systems worldwide have prioritized COVID-19 diagnostics, leading to a decrease in the overall demand for influenza diagnostic tests. The symptoms of COVID-19 and influenza often overlap, making it challenging to differentiate between the two based solely on clinical presentations. Further, the pandemic has also influenced healthcare spending priorities, potentially affecting investments in diagnostic technologies for influenza and hindering the market's expansion.
The molecular diagnostic assay segment is expected to be the largest during the forecast period
The molecular diagnostic assay segment is estimated to hold the largest share due to a category of tests that utilize molecular biology techniques to detect and identify influenza viruses. These tests are known for their high sensitivity, specificity, and capacity to distinguish between different influenza subtypes. Moreover, they contribute to a more comprehensive understanding of the genetic characteristics of circulating influenza viruses using prominent methods like reverse transcription-polymerase chain reaction (RT-PCR), boosting this segment's growth.
The research laboratories segment is expected to have the highest CAGR during the forecast period
The research laboratories segment is anticipated to have highest CAGR during the forecast period, due to they play a pivotal role in advancing the field of influenza diagnostics by conducting studies that aim to enhance the sensitivity, specificity, and efficiency of existing tests. They engage in the development of novel diagnostic assays, such as advanced molecular techniques, point-of-care testing devices, and serological assays. Furthermore, Research laboratories also play a key role in validating new diagnostic technologies providing essential data to guide healthcare practitioners propelling this segment's expansion.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period owing to a growing adoption of advanced diagnostic technologies, including molecular assays like PCR, as they offer higher sensitivity and specificity. This region is home to some of the major key markets, such as BioConcept, Abbott, Quidel Corporation, and Thermo Fisher Scientific Inc. In addition, the region's high population density and interconnectedness emphasize the need for effective influenza surveillance and control measures that drive the market in this region.
Region with highest CAGR:
North America is expected to witness highest CAGR over the projection period, owing to a well-established healthcare infrastructure and a high level of awareness regarding infectious diseases. There is a widespread adoption of molecular diagnostic assays such as RT-PCR, which offer high sensitivity and accuracy in influenza detection. Moreover, continuous innovation in diagnostic technologies, ensuring that they align with emerging viral strains and global health challenges, thereby boosts this region's growth.
Key players in the market
Some of the key players in the Influenza Diagnostic Tests Market include Becton, Dickinson and Company , Coris BioConcept, Meridian Bioscience Inc., Abbott, Sekisui Diagnostics, F. Hoffmann-La Roche Ltd, Hologic Inc., DiaSorin SpA, Quidel Corporation and Thermo Fischer Scientific Inc.
Key Developments:
In September 2023, Navigate BioPharma Services, Inc., announced a strategic collaboration with BD (Becton, Dickinson and Company), to explore opportunities to develop and commercialize flow cytometry-based companion diagnostics and tools for clinical decisions.
In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.
In July 2023, Thermo Fisher Scientific Inc. announced it has entered into a definitive agreement to acquire CorEvitas, LLC ("CorEvitas"), for approved medical treatments and therapies, from Audax Private Equity ("Audax").
In May 2023, Thermo Fisher, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of Indonesia (BRIN, Badan Riset dan Inovasi Nasional) to enable and enhance the country's national research and innovation infrastructure and capability.
Test Types Covered:
- Molecular Diagnostic Assay
- Traditional Diagnostic Test
- Other Test Types
End Users Covered:
- Research Laboratories
- Hospitals
- Diagnostics Centers
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Influenza Diagnostic Tests Market, By Test Type
- 5.1 Introduction
- 5.2 Molecular Diagnostic Assay
- 5.2.1 Simple Amplification-Based Assay (SAMBA)
- 5.2.2 RT-PCR
- 5.2.3 Nucleic Acid Sequence-Based Amplification Test (NASBAT)
- 5.2.4 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
- 5.2.5 Other Molecular Diagnostic Assays
- 5.3 Traditional Diagnostic Test
- 5.3.1 Viral Culture
- 5.3.2 Rapid Influenza Diagnostic Test (RIDT)
- 5.3.3 Serological Assay
- 5.3.4 Direct Fluorescent Antibody Test (DFAT)
- 5.4 Other Test Types
6 Global Influenza Diagnostic Tests Market, By End User
- 6.1 Introduction
- 6.2 Research Laboratories
- 6.3 Hospitals
- 6.4 Diagnostics Centers
- 6.5 Other End Users
7 Global Influenza Diagnostic Tests Market, By Geography
- 7.1 Introduction
- 7.2 North America
- 7.2.1 US
- 7.2.2 Canada
- 7.2.3 Mexico
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 Italy
- 7.3.4 France
- 7.3.5 Spain
- 7.3.6 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 New Zealand
- 7.4.6 South Korea
- 7.4.7 Rest of Asia Pacific
- 7.5 South America
- 7.5.1 Argentina
- 7.5.2 Brazil
- 7.5.3 Chile
- 7.5.4 Rest of South America
- 7.6 Middle East & Africa
- 7.6.1 Saudi Arabia
- 7.6.2 UAE
- 7.6.3 Qatar
- 7.6.4 South Africa
- 7.6.5 Rest of Middle East & Africa
8 Key Developments
- 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 8.2 Acquisitions & Mergers
- 8.3 New Product Launch
- 8.4 Expansions
- 8.5 Other Key Strategies
9 Company Profiling
- 9.1 Becton, Dickinson and Company
- 9.2 Coris BioConcept
- 9.3 Meridian Bioscience Inc.
- 9.4 Abbott
- 9.5 Sekisui Diagnostics
- 9.6 F. Hoffmann-La Roche Ltd
- 9.7 Hologic Inc.
- 9.8 DiaSorin SpA
- 9.9 Quidel Corporation
- 9.10 Thermo Fischer Scientific Inc.
List of Tables
- Table 1 Global Influenza Diagnostic Tests Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 3 Global Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 4 Global Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 5 Global Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 6 Global Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 7 Global Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 8 Global Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 9 Global Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 10 Global Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 7 Global Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 8 Global Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 9 Global Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 14 Global Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 15 Global Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 16 Global Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 17 Global Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 18 Global Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 19 Global Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 20 North America Influenza Diagnostic Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 21 North America Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 22 North America Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 23 North America Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 24 North America Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 25 North America Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 26 North America Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 27 North America Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 28 North America Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 29 North America Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 30 North America Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 31 North America Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 32 North America Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 33 North America Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 34 North America Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 35 North America Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 36 North America Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 37 North America Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 38 North America Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 39 Europe Influenza Diagnostic Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 40 Europe Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 41 Europe Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 42 Europe Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 43 Europe Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 44 Europe Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 45 Europe Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 46 Europe Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 47 Europe Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 48 Europe Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 49 Europe Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 50 Europe Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 51 Europe Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 52 Europe Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 53 Europe Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 54 Europe Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 55 Europe Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 56 Europe Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 57 Europe Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 58 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 59 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 60 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 61 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 62 Asia Pacific Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 63 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 64 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 65 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 66 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 67 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 68 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 69 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 70 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 71 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 72 Asia Pacific Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 73 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 74 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 75 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 76 Asia Pacific Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 77 South America Influenza Diagnostic Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 78 South America Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 79 South America Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 80 South America Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 81 South America Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 82 South America Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 83 South America Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 84 South America Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 85 South America Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 86 South America Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 87 South America Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 88 South America Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 89 South America Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 90 South America Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 91 South America Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 92 South America Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 93 South America Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 94 South America Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 95 South America Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 96 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Country (2021-2030) ($MN)
- Table 97 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Test Type (2021-2030) ($MN)
- Table 98 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Molecular Diagnostic Assay (2021-2030) ($MN)
- Table 99 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Simple Amplification-Based Assay (SAMBA) (2021-2030) ($MN)
- Table 100 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By RT-PCR (2021-2030) ($MN)
- Table 101 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Nucleic Acid Sequence-Based Amplification Test (NASBAT) (2021-2030) ($MN)
- Table 102 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Loop-Mediated Isothermal Amplification-Based Assay (LAMP) (2021-2030) ($MN)
- Table 103 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Other Molecular Diagnostic Assays (2021-2030) ($MN)
- Table 104 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Traditional Diagnostic Test (2021-2030) ($MN)
- Table 105 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Viral Culture (2021-2030) ($MN)
- Table 106 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Rapid Influenza Diagnostic Test (RIDT) (2021-2030) ($MN)
- Table 107 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Serological Assay (2021-2030) ($MN)
- Table 108 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Direct Fluorescent Antibody Test (DFAT) (2021-2030) ($MN)
- Table 109 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Other Test Types (2021-2030) ($MN)
- Table 110 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By End User (2021-2030) ($MN)
- Table 111 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Research Laboratories (2021-2030) ($MN)
- Table 112 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 113 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Diagnostics Centers (2021-2030) ($MN)
- Table 114 Middle East & Africa Influenza Diagnostic Tests Market Outlook, By Other End Users (2021-2030) ($MN)
